NEW YORK, Jan. 24 - Ecopia BioSciences said today that its genome scanning technology was recognized by the Canadian Patent Office as "novel and inventive."
In addition to the Notice of Allowance issued by the patent office, Ecopia said it has patents pending in the
The Montreal-based company's high throughput gene clustering discovery method begins by sequencing short segments of DNA called gene sequence tags, which are then compared to the company's database of microbial gene clusters involved in biosynthesis, according to the company. After a GST is matched to a gene cluster from the database, researchers identify genes next to the GST and assemble the target gene cluster.
Ecopia said it is using the technology to hunt for antibacterial, antifungal, and anticancer agents.